Literature DB >> 24195177

Microalbuminuria as a risk factor for cardiovascular disease in healthy individuals: a case report and review of the literature.

Adam Macarthur Noyes1, Karen Eckardt.   

Abstract

Cardiovascular disease without significant traditional risk factors is uncommon. Microalbuminuria has been linked with an increased risk of cardiovascular disease in the diabetic and hypertensive patient. However, a similar influence of microalbuminuria on risk for cardiovascular disease occurs in individuals without diabetes or hypertension, and predicts all-cause and cardiovascular disease mortality in the nondiabetic and general population. Microalbuminuriais a risk factor commonly overlooked despite evidence of being an independent marker for cardiovascular disease. We report a case of a myocardial infarction occurring in an otherwise healthy 64-year-old male with microalbuminuria, without traditional cardiovascular risk factors. Awareness of microalbuminuria as an early diagnostic marker for cardiovascular disease (CVD) is essential in the risk assessment of otherwise healthy individuals.

Entities:  

Mesh:

Year:  2013        PMID: 24195177

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  2 in total

1.  A hypertension emergency department intervention aimed at decreasing disparities: Design of a randomized clinical trial.

Authors:  Heather M Prendergast; Marina Del Rios; Renee Petzel-Gimbar; Daniel Garside; Sara Heinert; Sandra Escobar-Schulz; Pavitra Kotini-Shah; Michael Brown; Jinsong Chen; Joseph Colla; Marian Fitzgibbon; Ramon A Durazo-Arvizu; Martha Daviglus
Journal:  Contemp Clin Trials       Date:  2017-11-08       Impact factor: 2.226

2.  Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway.

Authors:  Trayambak Basak; Vinay Singh Tanwar; Gourav Bhardwaj; Nitin Bhardwaj; Shadab Ahmad; Gaurav Garg; Sreenivas V; Ganesan Karthikeyan; Sandeep Seth; Shantanu Sengupta
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.